Beta-lactam compounds as apparently uncompetitive inhibitors of HIV-1 protease
- 12 May 2005
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 15 (12), 3086-3090
- https://doi.org/10.1016/j.bmcl.2005.04.020
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- A unidirectional crosslinking strategy for HIV-1 protease dimerization inhibitorsBioorganic & Medicinal Chemistry Letters, 2004
- Synthesis of potent and highly selective nonguanidine azetidinone inhibitors of human tryptaseBioorganic & Medicinal Chemistry Letters, 2004
- Solid-phase synthesis and SAR of 4-carboxy-2-azetidinone mechanism-based tryptase inhibitorsBioorganic & Medicinal Chemistry Letters, 2004
- Synthesis and anti-HCMV activity of 1-acyl-β-lactams and 1-acylazetidines derived from phenylalanineBioorganic & Medicinal Chemistry Letters, 2004
- Inhibition of HIV protease by monoclonal antibodiesJournal of Molecular Recognition, 2002
- Solution-phase synthesis of a combinatorial monocyclic β-lactam library: Potential protease inhibitorsBioorganic & Medicinal Chemistry Letters, 1997
- Activity of Tethered Human Immunodeficiency Virus 1 Protease Containing Mutations in the Flap Region of One SubunitEuropean Journal of Biochemistry, 1997
- The inhibition of human immunodeficiency virus proteases by ‘interface peptides’Antiviral Research, 1996
- Comparison of the HIV‐1 and HIV‐2 proteinases using oligopeptide substrates representing cleavage sites in Gag and Gag‐Pol polyproteinsFEBS Letters, 1991
- The effect of salt on the Michaelis Menten constant of the HIV‐1 protease correlates with the Hofmeister seriesFEBS Letters, 1991